AR011422A1 - Compuestos derivados de indolil piperidinil tiadiazolo quinolein dioxido, un procedimiento para prepararlos y formulaciones farmaceuticasque los comprenden - Google Patents
Compuestos derivados de indolil piperidinil tiadiazolo quinolein dioxido, un procedimiento para prepararlos y formulaciones farmaceuticasque los comprendenInfo
- Publication number
- AR011422A1 AR011422A1 ARP980100185A ARP980100185A AR011422A1 AR 011422 A1 AR011422 A1 AR 011422A1 AR P980100185 A ARP980100185 A AR P980100185A AR P980100185 A ARP980100185 A AR P980100185A AR 011422 A1 AR011422 A1 AR 011422A1
- Authority
- AR
- Argentina
- Prior art keywords
- piperidinyl
- dioxide
- understand
- procedure
- pharmaceutical formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos derivados de indolil piperidinil tiadiazolo quinoleín dioxido de formula (I), donde R1 es hidrogeno, C1-4 alquil, C1-4 alcoxi o halo, y R2es hidrogeno, C1-4 alquil o C1-4 alcoxi; o una sal de los mismos. Un procedimiento paraprepararlos y formulaciones farmacéuticas que loscomprenden. Los compuestos y sus sales farmacéuticamente aceptables son indicados para ser utilizados en el tratamiento de trastornos del sistemanervioso central. Son activos en pruebas in vitro que indican modulacion serotonérgica, y en particular, actividad de union en el receptor 5-HT2A.Asimismo, inhiben considerablemente la reabsorcion de serotonina y presentan muy baja afinidad en relectores alfa y D2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9700895.7A GB9700895D0 (en) | 1997-01-17 | 1997-01-17 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011422A1 true AR011422A1 (es) | 2000-08-16 |
Family
ID=10806121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100185A AR011422A1 (es) | 1997-01-17 | 1998-01-16 | Compuestos derivados de indolil piperidinil tiadiazolo quinolein dioxido, un procedimiento para prepararlos y formulaciones farmaceuticasque los comprenden |
Country Status (29)
Country | Link |
---|---|
US (1) | US20010053783A1 (es) |
EP (1) | EP0854146B1 (es) |
JP (1) | JPH10204090A (es) |
KR (1) | KR20000070221A (es) |
AR (1) | AR011422A1 (es) |
AT (1) | ATE190617T1 (es) |
AU (1) | AU5569298A (es) |
CA (1) | CA2227132A1 (es) |
CZ (1) | CZ290318B6 (es) |
DE (1) | DE69800092T2 (es) |
DK (1) | DK0854146T3 (es) |
EA (1) | EA001469B1 (es) |
ES (1) | ES2144888T3 (es) |
GB (1) | GB9700895D0 (es) |
GR (1) | GR3033316T3 (es) |
HU (1) | HUP0000854A3 (es) |
ID (1) | ID21920A (es) |
IL (1) | IL129647A (es) |
NO (1) | NO993372D0 (es) |
NZ (1) | NZ335493A (es) |
PE (1) | PE99399A1 (es) |
PL (1) | PL334569A1 (es) |
PT (1) | PT854146E (es) |
SI (1) | SI0854146T1 (es) |
SV (1) | SV1998000088A (es) |
TR (1) | TR199901583T2 (es) |
TW (1) | TW396156B (es) |
WO (1) | WO1998031686A1 (es) |
ZA (1) | ZA98300B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0897921A1 (en) * | 1997-08-22 | 1999-02-24 | Eli Lilly And Company Limited | Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
GB9825413D0 (en) | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
GB9903784D0 (en) * | 1999-02-18 | 1999-04-14 | Lilly Co Eli | Pharmaceutical compounds |
AR028945A1 (es) * | 2000-06-19 | 2003-05-28 | Lundbeck & Co As H | Derivados de indol |
KR101165996B1 (ko) | 2010-04-23 | 2012-07-18 | 주식회사 녹십자 | 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 |
CN105949190B (zh) * | 2016-07-04 | 2018-06-29 | 烟台凯博医药科技有限公司 | 一种制备1,8-萘啶及衍生物的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662696A2 (fr) * | 1989-12-13 | 1991-12-06 | Rhone Poulenc Sante | Antagonistes de la serotonine, leur preparation et medicaments les contenant. |
DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1997
- 1997-01-17 GB GBGB9700895.7A patent/GB9700895D0/en active Pending
-
1998
- 1998-01-13 TW TW087100373A patent/TW396156B/zh not_active IP Right Cessation
- 1998-01-13 US US09/005,995 patent/US20010053783A1/en not_active Abandoned
- 1998-01-14 PL PL98334569A patent/PL334569A1/xx unknown
- 1998-01-14 ZA ZA98300A patent/ZA98300B/xx unknown
- 1998-01-14 ES ES98300249T patent/ES2144888T3/es not_active Expired - Lifetime
- 1998-01-14 EA EA199900667A patent/EA001469B1/ru not_active IP Right Cessation
- 1998-01-14 WO PCT/GB1998/000113 patent/WO1998031686A1/en not_active Application Discontinuation
- 1998-01-14 DK DK98300249T patent/DK0854146T3/da active
- 1998-01-14 EP EP98300249A patent/EP0854146B1/en not_active Expired - Lifetime
- 1998-01-14 HU HU0000854A patent/HUP0000854A3/hu unknown
- 1998-01-14 KR KR1019997006447A patent/KR20000070221A/ko not_active Application Discontinuation
- 1998-01-14 AT AT98300249T patent/ATE190617T1/de not_active IP Right Cessation
- 1998-01-14 ID IDW990623A patent/ID21920A/id unknown
- 1998-01-14 DE DE69800092T patent/DE69800092T2/de not_active Expired - Fee Related
- 1998-01-14 PT PT98300249T patent/PT854146E/pt unknown
- 1998-01-14 TR TR1999/01583T patent/TR199901583T2/xx unknown
- 1998-01-14 NZ NZ335493A patent/NZ335493A/xx unknown
- 1998-01-14 SI SI9830009T patent/SI0854146T1/xx unknown
- 1998-01-14 AU AU55692/98A patent/AU5569298A/en not_active Abandoned
- 1998-01-14 JP JP10005897A patent/JPH10204090A/ja active Pending
- 1998-01-14 CZ CZ19991510A patent/CZ290318B6/cs not_active IP Right Cessation
- 1998-01-14 IL IL12964798A patent/IL129647A/en not_active IP Right Cessation
- 1998-01-15 CA CA002227132A patent/CA2227132A1/en not_active Abandoned
- 1998-01-16 AR ARP980100185A patent/AR011422A1/es unknown
- 1998-07-09 PE PE1998000607A patent/PE99399A1/es not_active Application Discontinuation
- 1998-07-16 SV SV1998000088A patent/SV1998000088A/es unknown
-
1999
- 1999-07-08 NO NO993372A patent/NO993372D0/no not_active Application Discontinuation
-
2000
- 2000-04-26 GR GR20000401000T patent/GR3033316T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR001332A1 (es) | Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen. | |
AR007617A1 (es) | Compuestos de sulfonamidas, un medicamento que contiene a dichos compuestos y un procedimiento para la preparacion de los mismos. | |
IS1904B (is) | Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum | |
ES2162656T3 (es) | Derivados de quinazolina. | |
ES2164889T3 (es) | Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas. | |
NZ208529A (en) | 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions | |
BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
DK101990D0 (da) | 3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese | |
MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
MX9301348A (es) | Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende. | |
MX9300786A (es) | Compuestos hipolipidaemicos. | |
NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
DK0934309T3 (da) | Nye pyridylalkansyreamider som cytostatiske og immunosuppressive midler | |
DK0490772T3 (da) | 1,4-disubstituerede piperaziner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, der indeholder dem | |
ES2159017T3 (es) | 2-aminoindanos como ligandos selectivos de la dopamina d3. | |
IL63765A0 (en) | Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations containing them and their use | |
AR011422A1 (es) | Compuestos derivados de indolil piperidinil tiadiazolo quinolein dioxido, un procedimiento para prepararlos y formulaciones farmaceuticasque los comprenden | |
ES2152682T3 (es) | Derivados de indolina utiles como antagonistas del receptor 5ht-2c. | |
AR008243A1 (es) | Un derivado de 1-[6-(piridin-3-iloxi)-pirid(az)in-3-ilcarbamoil]indolina, un procedimiento para su preparacion, composicion farmaceutica y su uso para lafabricacion de un medicamento | |
AR013836A1 (es) | Compuestos espiro [ciclohexil]piperazinilo y composiciones farmaceuticas que los contienen activos como ligandos de un subtipo de receptor de dopamina. | |
AR033779A1 (es) | Compuestos utiles en la enfermedad de reflujo | |
ES2036178T3 (es) | Procedimiento para preparar nuevas benzamidas. | |
ES557149A0 (es) | Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. | |
ES2164283T3 (es) | Indanilidinacetilguanidinas sustituidas como inhibidores del intercambio de na+/h+, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico y medicamentos que las contienen. | |
NO991589L (no) | Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler |